Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

GlaxoSmithKline Nigeria Poised for a 22-Month Low

Feb. 28 (Bloomberg) -- GlaxoSmithKline Consumer Nigeria Plc, the local unit of the U.K.’s biggest drugmaker, headed for its lowest level in 22 months after the company’s dividend announcement fell below investors’ expectations.

The stock dropped 5 percent to 20.90 naira at 14.31 p.m. in Lagos, the commercial capital, on course for its lowest since April 2010. The shares have declined 9 percent this year, compared with a 3 percent retreat in the Nigerian Stock Exchange All-Share Index, according to data compiled by Bloomberg.

GlaxoSmithKline will pay a 1.20-naira per share dividend for the 2011 full-year, the company said in a statement published on the website of the Nigerian Stock Exchange today.

The dividend “is too small for a 21-naira stock,” Raheem Mohammed, chief operating officer of Lagos-based Kundila Finance, a brokerage, said by phone today. “Investors want stocks on which they can get both dividends and capital appreciation,” he said.

To contact the reporter on this story: Vincent Nwanma in Lagos at vnwanma@bloomberg.net

To contact the editor responsible for this story: Dulue Mbachu at dmbachu@bloomberg.net

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.